Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
European Journal of Medicinal Chemistry
|
November 1, 2015
Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model
Ken-Ming Chang, Huang-Hui Chen, Tai-Chi Wang, et al.
Chemical Research in Toxicology
|
August 15, 2015
Novel Nrf2/ARE activator, trans-Coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathway
Huang-Hui Chen, Tai-Chi Wang, Yen-Chen Lee, et al.
Pharmacological Research
|
December 21, 2024
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models
Ya-Chu Tang, Jing-Jim Ou, Shu-Ching Hsu, et al.
Journal of Medicinal Chemistry
|
November 26, 2024
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization
Hsin-Huei Chang, Lung-Chun Lee, Tsu Hsu, et al.
Developmental Cell
|
March 29, 2025
KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubules
Yuan-Shao Pao, Kuan-Ju Liao, Ya-Chia Shiau, et al.
Bioorganic Chemistry
|
March 2, 2018
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy
Shu-Yu Lin, Teng-Kuang Yeh, Jen-Shin Song, et al.
European Journal of Medicinal Chemistry
|
December 20, 2021
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design
Teng-Kuang Yeh, Jen-Shin Song, Po-Wei Chang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
European Journal of Medicinal Chemistry
|
November 1, 2015
Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model
Ken-Ming Chang, Huang-Hui Chen, Tai-Chi Wang, et al.
Chemical Research in Toxicology
|
August 15, 2015
Novel Nrf2/ARE activator, trans-Coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathway
Huang-Hui Chen, Tai-Chi Wang, Yen-Chen Lee, et al.
Pharmacological Research
|
December 21, 2024
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models
Ya-Chu Tang, Jing-Jim Ou, Shu-Ching Hsu, et al.
Journal of Medicinal Chemistry
|
November 26, 2024
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization
Hsin-Huei Chang, Lung-Chun Lee, Tsu Hsu, et al.
Developmental Cell
|
March 29, 2025
KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubules
Yuan-Shao Pao, Kuan-Ju Liao, Ya-Chia Shiau, et al.
Bioorganic Chemistry
|
March 2, 2018
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy
Shu-Yu Lin, Teng-Kuang Yeh, Jen-Shin Song, et al.
European Journal of Medicinal Chemistry
|
December 20, 2021
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design
Teng-Kuang Yeh, Jen-Shin Song, Po-Wei Chang, et al.
Page
of 3